Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?-Reference-Cited by-同舟云学术

Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?

Published:2018-06-05 Issue:4 Volume:2 Page:313-318
ISSN:2475-0328
Container-title:Annals of Gastroenterological Surgery
language:en
Short-container-title:Ann Gastroenterol Surg

Author:

Ito Masaaki¹²,Oshima Yoko¹,Yajima Satoshi¹,Suzuki Takashi¹,Nanami Tatsuki¹,Shiratori Fumiaki¹,Funahashi Kimihiko¹,Nemoto Tetsuo³,Shimada Hideaki¹²^ORCID

Affiliation:

1. Department of Surgery; Toho University School of Medicine; Tokyo Japan

2. Department of Clinical Oncology; Toho University School of Medicine; Tokyo Japan

3. Department of Surgical Pathology; Toho University School of Medicine; Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Gastroenterology,Surgery

Reference18 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

2. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations;Gong;J Immunother Cancer,2018

3. Tackling cancer resistance by immunotherapy: updated clinical impact and safety of PD-1/PD-L1 Inhibitors;Abdin;Cancers (Basel),2018

4. PD-L1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer;Amatatsu;Cancer Sci,2018

5. Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients;Xing;Oncoimmunology,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

2. Fabrication of electrochemiluminescence aptasensor for PD-L1 detection based on luminescent CdS@Ce-MOF@Au;Microchemical Journal;2023-10

3. Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients;Gastric Cancer;2023-09-05

4. The predictive role of soluble programmed death ligand 1 in digestive system cancers;Frontiers in Oncology;2023-07-13

5. Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers;Biomarkers;2023-07-02